Phosphodiesterases regulate airway smooth muscle function in health and disease.
On the basis of structure, regulation, and kinetic properties, phosphodiesterases (PDEs) represent a superfamily of enzymes divided into 11 subfamilies that catalyze cytosolic levels of 3',5'-cyclic adenosine monophosphate (cAMP) or 3',5'-cyclic guanosine monophosphate (cGMP) to 5'-AMP or 5'-GMP, respectively. PDE4 represents the major PDE expressed in inflammatory cells as well as airway smooth muscle (ASM), and selective PDE4 inhibitors provide a broad spectrum of anti-inflammatory effects such as abrogating cytokine and chemokine release from inflammatory cells and inhibiting inflammatory cell trafficking. Due to cell- and tissue-specific gene expression and regulation, PDEs modulate unique organ-based functions. New tools or compounds that selectively inhibit PDE subfamilies and genetically engineered mice deficient in selective isoforms have greatly enhanced our understanding of PDE function in airway inflammation and resident cell function. This chapter will focus on recent advances in our understanding of the role of PDE in regulating ASM function.
Krymskaya
Vera P
VP
Department of Medicine, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Panettieri
Reynold A
RA
D000403:Airway Resistance; D000818:Animals; D018925:Chemokines / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D009130:Muscle, Smooth / Q000201:enzymology* / Q000502:physiology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D012137:Respiratory System / Q000033:anatomy & histology* / Q000201:enzymology
D018925:Chemokines; D016207:Cytokines; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases